Comments to the FDA regarding the North American Bioproducts Corp. (NABC) Food Additive Petition for Erythromycin Thiocyanate (Animal Use) and recommending that the FDA not approve the addition of the critically important human drug erythromycin to animal feed due to the risk to public health from the development of antimicrobial resistance.